25 XP   0   0   10

Lucid Diagnostics Inc
Buy, Hold or Sell?

Let's analyse Lucid Diagnostics Inc together

PenkeI guess you are interested in Lucid Diagnostics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lucid Diagnostics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lucid Diagnostics Inc

I send you an email if I find something interesting about Lucid Diagnostics Inc.

Quick analysis of Lucid Diagnostics Inc (30 sec.)










What can you expect buying and holding a share of Lucid Diagnostics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.05
Expected worth in 1 year
$-0.57
How sure are you?
15.4%

+ What do you gain per year?

Total Gains per Share
$-0.53
Return On Investment
-76.9%

For what price can you sell your share?

Current Price per Share
$0.68
Expected price per share
$0 - $1.14
How sure are you?
50%

1. Valuation of Lucid Diagnostics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.68

Intrinsic Value Per Share

$-12.70 - $-15.04

Total Value Per Share

$-12.75 - $-15.09

2. Growth of Lucid Diagnostics Inc (5 min.)




Is Lucid Diagnostics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.3m$35.3m-$25.3m-251.9%

How much money is Lucid Diagnostics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$503.9m-$13.7m-$490.1m-97.3%
Net Profit Margin-113,447.8%-8,955.7%--

How much money comes from the company's main activities?

3. Financial Health of Lucid Diagnostics Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#315 / 334

Most Revenue
#276 / 334

Most Profit
#334 / 334

Most Efficient
#332 / 334

What can you expect buying and holding a share of Lucid Diagnostics Inc? (5 min.)

Welcome investor! Lucid Diagnostics Inc's management wants to use your money to grow the business. In return you get a share of Lucid Diagnostics Inc.

What can you expect buying and holding a share of Lucid Diagnostics Inc?

First you should know what it really means to hold a share of Lucid Diagnostics Inc. And how you can make/lose money.

Speculation

The Price per Share of Lucid Diagnostics Inc is $0.6831. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lucid Diagnostics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lucid Diagnostics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.05. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lucid Diagnostics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.22-32.9%-0.27-40.0%-0.29-42.6%-0.22-32.5%-0.22-32.5%
Usd Book Value Change Per Share-0.10-14.8%-0.13-19.2%-0.16-24.0%0.00-0.5%0.00-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-14.8%-0.13-19.2%-0.16-24.0%0.00-0.5%0.00-0.5%
Usd Price Per Share1.41-1.34-2.13-1.48-1.48-
Price to Earnings Ratio-1.57--1.27--1.89--1.41--1.41-
Price-to-Total Gains Ratio-13.98-2.76--9.67--1.84--1.84-
Price to Book Ratio-29.44--0.05-2.87-1.23-1.23-
Price-to-Total Gains Ratio-13.98-2.76--9.67--1.84--1.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6831
Number of shares1463
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.130.00
Usd Total Gains Per Share-0.130.00
Gains per Quarter (1463 shares)-192.24-5.39
Gains per Year (1463 shares)-768.97-21.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-769-7790-22-32
20-1538-15480-43-54
30-2307-23170-65-76
40-3076-30860-86-98
50-3845-38550-108-120
60-4614-46240-129-142
70-5383-53930-151-164
80-6152-61620-173-186
90-6921-69310-194-208
100-7690-77000-216-230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.08.02.016.7%2.09.02.015.4%2.09.02.015.4%2.09.02.015.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share1.03.00.025.0%2.08.02.016.7%2.09.02.015.4%2.09.02.015.4%2.09.02.015.4%

Fundamentals of Lucid Diagnostics Inc

About Lucid Diagnostics Inc

Lucid Diagnostics Inc., a commercial-stage medical diagnostics technology company, focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma in the United States. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. Lucid Diagnostics Inc. was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Fundamental data was last updated by Penke on 2024-04-21 23:45:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lucid Diagnostics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lucid Diagnostics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lucid Diagnostics Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -1,041.3% means that $-10.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lucid Diagnostics Inc:

  • The MRQ is -1,041.3%. The company is making a huge loss. -2
  • The TTM is -113,447.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,041.3%TTM-113,447.8%+112,406.4%
TTM-113,447.8%YOY-8,955.7%-104,492.1%
TTM-113,447.8%5Y-38,220.1%-75,227.7%
5Y-38,220.1%10Y-38,220.1%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,041.3%-12.4%-1,028.9%
TTM-113,447.8%-20.4%-113,427.4%
YOY-8,955.7%-14.8%-8,940.9%
5Y-38,220.1%-21.3%-38,198.8%
10Y-38,220.1%-25.0%-38,195.1%
1.1.2. Return on Assets

Shows how efficient Lucid Diagnostics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lucid Diagnostics Inc to the Medical Devices industry mean.
  • -39.7% Return on Assets means that Lucid Diagnostics Inc generated $-0.40 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lucid Diagnostics Inc:

  • The MRQ is -39.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1,034.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.7%TTM-1,034.6%+994.8%
TTM-1,034.6%YOY-33.5%-1,001.0%
TTM-1,034.6%5Y-378.5%-656.0%
5Y-378.5%10Y-378.5%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.7%-4.1%-35.6%
TTM-1,034.6%-4.7%-1,029.9%
YOY-33.5%-4.8%-28.7%
5Y-378.5%-4.0%-374.5%
10Y-378.5%-5.2%-373.3%
1.1.3. Return on Equity

Shows how efficient Lucid Diagnostics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lucid Diagnostics Inc to the Medical Devices industry mean.
  • 0.0% Return on Equity means Lucid Diagnostics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lucid Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,144.6%+2,144.6%
TTM-2,144.6%YOY-44.3%-2,100.3%
TTM-2,144.6%5Y-675.1%-1,469.5%
5Y-675.1%10Y-675.1%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.2%+4.2%
TTM-2,144.6%-5.8%-2,138.8%
YOY-44.3%-5.7%-38.6%
5Y-675.1%-6.3%-668.8%
10Y-675.1%-7.1%-668.0%

1.2. Operating Efficiency of Lucid Diagnostics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lucid Diagnostics Inc is operating .

  • Measures how much profit Lucid Diagnostics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lucid Diagnostics Inc to the Medical Devices industry mean.
  • An Operating Margin of -1,101.3% means the company generated $-11.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lucid Diagnostics Inc:

  • The MRQ is -1,101.3%. The company is operating very inefficient. -2
  • The TTM is -3,325.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,101.3%TTM-3,325.9%+2,224.6%
TTM-3,325.9%YOY-8,988.9%+5,663.0%
TTM-3,325.9%5Y-4,327.8%+1,001.9%
5Y-4,327.8%10Y-4,327.8%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,101.3%-24.3%-1,077.0%
TTM-3,325.9%-16.4%-3,309.5%
YOY-8,988.9%-13.7%-8,975.2%
5Y-4,327.8%-19.9%-4,307.9%
10Y-4,327.8%-24.5%-4,303.3%
1.2.2. Operating Ratio

Measures how efficient Lucid Diagnostics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 12.01 means that the operating costs are $12.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lucid Diagnostics Inc:

  • The MRQ is 12.012. The company is inefficient in keeping operating costs low. -1
  • The TTM is 33.545. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ12.012TTM33.545-21.533
TTM33.545YOY90.639-57.094
TTM33.5455Y43.863-10.318
5Y43.86310Y43.8630.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ12.0121.442+10.570
TTM33.5451.439+32.106
YOY90.6391.431+89.208
5Y43.8631.436+42.427
10Y43.8631.374+42.489

1.3. Liquidity of Lucid Diagnostics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lucid Diagnostics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.75 means the company has $0.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lucid Diagnostics Inc:

  • The MRQ is 0.751. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.194. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.751TTM1.194-0.443
TTM1.194YOY5.993-4.799
TTM1.1945Y3.279-2.084
5Y3.27910Y3.2790.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7512.726-1.975
TTM1.1942.732-1.538
YOY5.9933.510+2.483
5Y3.2793.617-0.338
10Y3.2793.499-0.220
1.3.2. Quick Ratio

Measures if Lucid Diagnostics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lucid Diagnostics Inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.64 means the company can pay off $0.64 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lucid Diagnostics Inc:

  • The MRQ is 0.645. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.131. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.645TTM1.131-0.486
TTM1.131YOY5.718-4.586
TTM1.1315Y2.119-0.988
5Y2.11910Y2.1190.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6451.491-0.846
TTM1.1311.633-0.502
YOY5.7182.113+3.605
5Y2.1192.295-0.176
10Y2.1192.255-0.136

1.4. Solvency of Lucid Diagnostics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lucid Diagnostics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lucid Diagnostics Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.08 means that Lucid Diagnostics Inc assets are financed with 108.5% credit (debt) and the remaining percentage (100% - 108.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lucid Diagnostics Inc:

  • The MRQ is 1.085. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.787. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.085TTM0.787+0.298
TTM0.787YOY0.212+0.575
TTM0.7875Y2.448-1.662
5Y2.44810Y2.4480.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0850.389+0.696
TTM0.7870.386+0.401
YOY0.2120.335-0.123
5Y2.4480.442+2.006
10Y2.4480.461+1.987
1.4.2. Debt to Equity Ratio

Measures if Lucid Diagnostics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lucid Diagnostics Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lucid Diagnostics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.699-3.699
TTM3.699YOY0.284+3.416
TTM3.6995Y1.232+2.468
5Y1.23210Y1.2320.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.551-0.551
TTM3.6990.554+3.145
YOY0.2840.479-0.195
5Y1.2320.622+0.610
10Y1.2320.674+0.558

2. Market Valuation of Lucid Diagnostics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lucid Diagnostics Inc generates.

  • Above 15 is considered overpriced but always compare Lucid Diagnostics Inc to the Medical Devices industry mean.
  • A PE ratio of -1.57 means the investor is paying $-1.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lucid Diagnostics Inc:

  • The EOD is -0.761. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.570. Based on the earnings, the company is expensive. -2
  • The TTM is -1.269. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.761MRQ-1.570+0.810
MRQ-1.570TTM-1.269-0.301
TTM-1.269YOY-1.888+0.619
TTM-1.2695Y-1.412+0.143
5Y-1.41210Y-1.4120.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.761-1.077+0.316
MRQ-1.570-1.704+0.134
TTM-1.269-2.081+0.812
YOY-1.888-2.978+1.090
5Y-1.412-2.379+0.967
10Y-1.412-1.726+0.314
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lucid Diagnostics Inc:

  • The EOD is -0.811. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.675. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.014. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.811MRQ-1.675+0.863
MRQ-1.675TTM-2.014+0.339
TTM-2.014YOY-3.061+1.047
TTM-2.0145Y-2.027+0.013
5Y-2.02710Y-2.0270.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.811-0.932+0.121
MRQ-1.675-1.578-0.097
TTM-2.014-2.973+0.959
YOY-3.061-6.318+3.257
5Y-2.027-5.307+3.280
10Y-2.027-5.171+3.144
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lucid Diagnostics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -29.44 means the investor is paying $-29.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Lucid Diagnostics Inc:

  • The EOD is -14.261. Based on the equity, the company is expensive. -2
  • The MRQ is -29.435. Based on the equity, the company is expensive. -2
  • The TTM is -0.047. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.261MRQ-29.435+15.175
MRQ-29.435TTM-0.047-29.388
TTM-0.047YOY2.874-2.922
TTM-0.0475Y1.234-1.281
5Y1.23410Y1.2340.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-14.2611.876-16.137
MRQ-29.4352.372-31.807
TTM-0.0472.434-2.481
YOY2.8743.217-0.343
5Y1.2343.893-2.659
10Y1.2344.245-3.011
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Lucid Diagnostics Inc.

3.1. Institutions holding Lucid Diagnostics Inc

Institutions are holding 3.664% of the shares of Lucid Diagnostics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Luminus Management, LLC1.6110.3015773246-101854-11.6391
2023-12-31Vanguard Group Inc0.6925033239168252.0963
2023-12-31Nantahala Capital Management, LLC0.62380.012629939614126189.3294
2023-12-31Bridgeway Capital Management, LLC0.28130.004113500000
2023-12-31Geode Capital Management, LLC0.2747013187100
2023-09-30Ayrton Capital LLC0.1540.586373907739070
2023-09-30Citadel Advisors Llc0.0758036375-26136-41.8102
2023-12-31Verition Fund Managegment, LLC0.07530.00043616600
2023-12-31Geneos Wealth Management Inc0.07050.00243385000
2023-12-31LPL Financial Corp0.068032630423014.8944
2023-12-31BlackRock Inc0.0489023453-288-1.2131
2023-12-31Virtu Financial LLC0.04340.002320836208360
2023-12-31JANE STREET GROUP, LLC0.0257012345-4977-28.7322
2023-12-31State Street Corporation0.021901052100
2023-12-31Wells Fargo & Co0.01890908140.0441
2023-12-31Byrne Asset Management LLC0.01380.00736610-600-8.3218
2023-12-31UBS Group AG0.0119057081923.4808
2023-12-31Advisor Group Holdings, Inc.0.00420200000
2023-12-31Tower Research Capital LLC0.002101015-1976-66.0649
2023-12-31Advisory Services Network, LLC0.001607657650
Total 4.11930.91691977166+112189+5.7%

3.2. Funds holding Lucid Diagnostics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.76050366924-1-0.0003
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.40210.000219399100
2023-12-31Bridgeway Ultra-Small Company Market0.27980.102413500000
2024-02-29Fidelity Extended Market Index0.1460.000270457-460-0.6486
2024-02-29Fidelity Total Market Index0.11810.000156986-24-0.0421
2024-03-28iShares Micro-Cap ETF0.04520.00192182300
2024-02-29Fidelity Nasdaq Composite Index0.02670.000112873-10-0.0776
2024-02-29Fidelity Series Total Market Index0.0254012237-29-0.2364
2024-03-31NT Ext Equity Mkt Idx Fd - L0.02340.000211276256029.3713
2023-12-31Northern Trust Extended Eq Market Idx0.01810.0002871600
2024-03-31BlackRock Extended Equity Market K0.00760365636560
2024-03-31State St US Extended Mkt Indx NL Cl C0.00680.0001328100
2024-02-29Spartan Extended Market Index Pool E0.00470.0001225133717.6071
2023-12-31SSgA U.S. Extended Market Index Class I0.00460.0001220000
2024-03-31Schwab Total Stock Market Index0.00410199800
2024-02-291290 VT Micro Cap K0.00330.0013157752349.6205
2024-02-29Spartan Total Market Index Pool E0.00180886-8-0.8949
2024-03-31BlackRock U.S. Equity Market F0.001507107100
2023-12-31SSgA U.S. Total Market Index Strategy0.00130635-15-2.3077
2024-03-31Extended Equity Market Fund M0.000904514510
Total 1.88190.1069907928+7690+0.8%

3.3. Insider Transactions

Insiders are holding 70.388% of the shares of Lucid Diagnostics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-25Stanley LapidusSELL2001.43
2023-09-20Stanley LapidusSELL38171.45

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Lucid Diagnostics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.101-0.131+30%-0.164+63%-0.004-96%-0.004-96%
Book Value Per Share---0.0480.208-123%0.734-107%0.264-118%0.264-118%
Current Ratio--0.7511.194-37%5.993-87%3.279-77%3.279-77%
Debt To Asset Ratio--1.0850.787+38%0.212+412%2.448-56%2.448-56%
Debt To Equity Ratio---3.699-100%0.284-100%1.232-100%1.232-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.224-0.273+22%-0.291+30%-0.222-1%-0.222-1%
Free Cash Flow Per Share---0.210-0.171-19%-0.183-13%-0.141-33%-0.141-33%
Free Cash Flow To Equity Per Share---0.107-0.019-83%0.163-166%0.232-146%0.232-146%
Gross Profit Margin--1.4071.258+12%1.336+5%1.210+16%1.210+16%
Intrinsic Value_10Y_max---15.042--------
Intrinsic Value_10Y_min---12.704--------
Intrinsic Value_1Y_max---0.733--------
Intrinsic Value_1Y_min---0.719--------
Intrinsic Value_3Y_max---2.792--------
Intrinsic Value_3Y_min---2.654--------
Intrinsic Value_5Y_max---5.563--------
Intrinsic Value_5Y_min---5.113--------
Market Cap32956022.880-106%68025168.00064768644.000+5%102640812.000-34%71439415.385-5%71439415.385-5%
Net Profit Margin---10.413-1134.478+10794%-89.557+760%-382.201+3570%-382.201+3570%
Operating Margin---11.013-33.259+202%-89.889+716%-43.278+293%-43.278+293%
Operating Ratio--12.01233.545-64%90.639-87%43.863-73%43.863-73%
Pb Ratio-14.261+52%-29.435-0.047-100%2.874-1124%1.234-2486%1.234-2486%
Pe Ratio-0.761+52%-1.570-1.269-19%-1.888+20%-1.412-10%-1.412-10%
Price Per Share0.683-106%1.4101.343+5%2.128-34%1.481-5%1.481-5%
Price To Free Cash Flow Ratio-0.811+52%-1.675-2.014+20%-3.061+83%-2.027+21%-2.027+21%
Price To Total Gains Ratio-6.771+52%-13.9772.757-607%-9.666-31%-1.836-87%-1.836-87%
Quick Ratio--0.6451.131-43%5.718-89%2.119-70%2.119-70%
Return On Assets---0.397-10.346+2505%-0.335-16%-3.785+853%-3.785+853%
Return On Equity----21.4460%-0.4430%-6.7510%-6.7510%
Total Gains Per Share---0.101-0.131+30%-0.164+63%-0.004-96%-0.004-96%
Usd Book Value---2311000.00010055500.000-123%35390000.000-107%12723104.077-118%12723104.077-118%
Usd Book Value Change Per Share---0.101-0.131+30%-0.164+63%-0.004-96%-0.004-96%
Usd Book Value Per Share---0.0480.208-123%0.734-107%0.264-118%0.264-118%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.224-0.273+22%-0.291+30%-0.222-1%-0.222-1%
Usd Free Cash Flow---10154000.000-8259500.000-19%-8842542.750-13%-6816446.846-33%-6816446.846-33%
Usd Free Cash Flow Per Share---0.210-0.171-19%-0.183-13%-0.141-33%-0.141-33%
Usd Free Cash Flow To Equity Per Share---0.107-0.019-83%0.163-166%0.232-146%0.232-146%
Usd Market Cap32956022.880-106%68025168.00064768644.000+5%102640812.000-34%71439415.385-5%71439415.385-5%
Usd Price Per Share0.683-106%1.4101.343+5%2.128-34%1.481-5%1.481-5%
Usd Profit---10830000.000-503916500.000+4553%-13758401.750+27%-161654498.231+1393%-161654498.231+1393%
Usd Revenue--1040000.000607000.000+71%122000.000+752%262769.231+296%262769.231+296%
Usd Total Gains Per Share---0.101-0.131+30%-0.164+63%-0.004-96%-0.004-96%
 EOD+2 -6MRQTTM+19 -14YOY+15 -185Y+12 -2110Y+12 -21

4.2. Fundamental Score

Let's check the fundamental score of Lucid Diagnostics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.761
Price to Book Ratio (EOD)Between0-1-14.261
Net Profit Margin (MRQ)Greater than0-10.413
Operating Margin (MRQ)Greater than0-11.013
Quick Ratio (MRQ)Greater than10.645
Current Ratio (MRQ)Greater than10.751
Debt to Asset Ratio (MRQ)Less than11.085
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.397
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Lucid Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5018.841
Ma 20Greater thanMa 500.848
Ma 50Greater thanMa 1001.068
Ma 100Greater thanMa 2001.238
OpenGreater thanClose0.730
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Stockholder Equity 23,0471,85924,906-9,83515,071-12,5152,556-4,867-2,311
Net Invested Capital  23,04713423,181-10,12513,056-9,6353,421-10,407-6,986



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets27,270
Total Liabilities29,581
Total Stockholder Equity-2,311
 As reported
Total Liabilities 29,581
Total Stockholder Equity+ -2,311
Total Assets = 27,270

Assets

Total Assets27,270
Total Current Assets22,073
Long-term Assets5,197
Total Current Assets
Cash And Cash Equivalents 18,896
Net Receivables 45
Other Current Assets 3,132
Total Current Assets  (as reported)22,073
Total Current Assets  (calculated)22,073
+/-0
Long-term Assets
Property Plant Equipment 2,641
Intangible Assets 1,424
Long-term Assets Other 1,132
Long-term Assets  (as reported)5,197
Long-term Assets  (calculated)5,197
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities29,382
Long-term Liabilities199
Total Stockholder Equity-2,311
Total Current Liabilities
Short-term Debt 15,056
Short Long Term Debt 13,950
Accounts payable 1,146
Other Current Liabilities 13,180
Total Current Liabilities  (as reported)29,382
Total Current Liabilities  (calculated)43,332
+/- 13,950
Long-term Liabilities
Long-term Liabilities  (as reported)199
Long-term Liabilities  (calculated)0
+/- 199
Total Stockholder Equity
Common Stock42
Retained Earnings -150,741
Other Stockholders Equity 129,805
Total Stockholder Equity (as reported)-2,311
Total Stockholder Equity (calculated)-20,894
+/- 18,583
Other
Capital Stock18,667
Cash and Short Term Investments 18,896
Common Stock Shares Outstanding 42,330
Liabilities and Stockholders Equity 27,270
Net Debt -3,641
Net Invested Capital -6,986
Net Working Capital -7,309
Property Plant and Equipment Gross 3,408
Short Long Term Debt Total 15,255



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
2,195
0
4,837
3,296
58,999
58,999
45,401
38,376
32,509
49,125
42,486
33,244
27,270
27,27033,24442,48649,12532,50938,37645,40158,99958,9993,2964,83702,1950
   > Total Current Assets 
1,440
1,440
1,311
4,075
2,505
57,303
57,303
35,875
29,847
24,356
41,721
35,749
27,303
22,073
22,07327,30335,74941,72124,35629,84735,87557,30357,3032,5054,0751,3111,4401,440
       Cash And Cash Equivalents 
0
111
0
2,231
21
53,656
53,656
32,679
26,934
22,474
39,522
32,570
24,050
18,896
18,89624,05032,57039,52222,47426,93432,67953,65653,656212,23101110
       Short-term Investments 
0
0
0
0
0
0
0
1,782
2,389
1,331
1,726
2,587
0
0
002,5871,7261,3312,3891,7820000000
       Net Receivables 
0
0
0
0
200
200
200
0
31
17
27
35
21
45
45213527173102002002000000
       Inventory 
834
834
740
699
805
493
493
280
104
111
62
42
190
278
2781904262111104280493493805699740834834
       Other Current Assets 
311
495
10
1,145
1,478
1,138
2,954
2,916
2,778
1,754
2,172,000
3,144,000
3,232,000
3,132
3,1323,232,0003,144,0002,172,0001,7542,7782,9162,9541,1381,4781,14510495311
   > Long-term Assets 
0
755
0
762
792
1,696
1,696
9,526
8,529
8,153
7,404
6,737
5,941
5,197
5,1975,9416,7377,4048,1538,5299,5261,6961,69679276207550
       Property Plant Equipment 
0
0
0
0
0
971
971
3,346
3,501
3,600
3,386
3,224
2,878
2,641
2,6412,8783,2243,3863,6003,5013,34697197100000
       Intangible Assets 
0
0
0
0
0
0
5,714,000
4,456
3,950
3,445
2,940
2,435
1,929
1,424
1,4241,9292,4352,9403,4453,9504,4565,714,000000000
       Long-term Assets Other 
0
755
0
762
792
0
725
1,724
1,078
1,108
1,078
1,078
1,134
1,132
1,1321,1341,0781,0781,1081,0781,724725079276207550
> Total Liabilities 
0
15,713
0
24,787
27,431
4,260
4,260
9,160
10,843
9,462
24,219
27,415
30,688
29,581
29,58130,68827,41524,2199,46210,8439,1604,2604,26027,43124,787015,7130
   > Total Current Liabilities 
15,713
15,713
18,439
24,787
27,431
4,260
4,260
7,878
9,700
8,425
23,393
26,683
30,224
29,382
29,38230,22426,68323,3938,4259,7007,8784,2604,26027,43124,78718,43915,71315,713
       Short-term Debt 
0
0
0
0
22,400,000,000
0
769
798
860
962
12,951
12,709
15,618
15,056
15,05615,61812,70912,951962860798769022,400,000,0000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
11,900
11,610
14,490
13,950
13,95014,49011,61011,9000000000000
       Accounts payable 
2,058
2,058
788
1,540
2,841
1,490
1,490
2,406
1,102
1,056
625
637
994
1,146
1,1469946376251,0561,1022,4061,4901,4902,8411,5407882,0582,058
       Other Current Liabilities 
10,584
13,656
13,894
23,247
24,590
1,657
2,770
4,674
7,738
6,407
9,817
13,337,000
13,612,000
13,180
13,18013,612,00013,337,0009,8176,4077,7384,6742,7701,65724,59023,24713,89413,65610,584
   > Long-term Liabilities 
0
2,058
0
1,540
2,841
0
1,490
1,282
1,143
1,037
826
732
464
199
1994647328261,0371,1431,2821,49002,8411,54002,0580
> Total Stockholder Equity
0
-13,518
0
-19,950
-24,134
54,739
54,739
36,241
27,533
23,047
24,906
15,071
2,556
-2,311
-2,3112,55615,07124,90623,04727,53336,24154,73954,739-24,134-19,9500-13,5180
   Common Stock
10
14
10
14
14
35
35
36
37
41
42
42
42
42
4242424241373635351414101410
   Retained Earnings Total Equity00-125,703-114,322-98,075-83,147-68,79800-30,5980000
   Accumulated Other Comprehensive Income -42-13,625,000-13,625,00000000000000
   Capital Surplus 
0
0
0
0
6,450
0
0
105,003
110,643
121,081
125,561
127,107
0
0
00127,107125,561121,081110,643105,003006,4500000
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
294
0
3,678
6,450
0
96,608
105,003
110,643
121,081
125,561
13,752,107
13,753,800
129,805
129,80513,753,80013,752,107125,561121,081110,643105,00396,60806,4503,67802940



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,428
Cost of Revenue-8,478
Gross Profit-6,050-6,050
 
Operating Income (+$)
Gross Profit-6,050
Operating Expense-42,432
Operating Income-48,482-48,482
 
Operating Expense (+$)
Research Development7,252
Selling General Administrative19,254
Selling And Marketing Expenses16,404
Operating Expense42,43242,910
 
Net Interest Income (+$)
Interest Income424
Interest Expense-416
Other Finance Cost-116
Net Interest Income-108
 
Pretax Income (+$)
Operating Income-48,482
Net Interest Income-108
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-52,666-44,298
EBIT - interestExpense = -48,898
-52,666
-52,250
Interest Expense416
Earnings Before Interest and Taxes (EBIT)-48,482-52,250
Earnings Before Interest and Taxes (EBITDA)-45,983
 
After tax Income (+$)
Income Before Tax-52,666
Tax Provision-0
Net Income From Continuing Ops-56,764-52,666
Net Income-52,666
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses50,910
Total Other Income/Expenses Net-4,184108
 

Technical Analysis of Lucid Diagnostics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lucid Diagnostics Inc. The general trend of Lucid Diagnostics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lucid Diagnostics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lucid Diagnostics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.95 < 1.04 < 1.14.

The bearish price targets are: .

Tweet this
Lucid Diagnostics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lucid Diagnostics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lucid Diagnostics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lucid Diagnostics Inc. The current macd is -0.09788752.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lucid Diagnostics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lucid Diagnostics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lucid Diagnostics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Lucid Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) ChartLucid Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lucid Diagnostics Inc. The current adx is 50.76.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lucid Diagnostics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Lucid Diagnostics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lucid Diagnostics Inc. The current sar is 0.86329921.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lucid Diagnostics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lucid Diagnostics Inc. The current rsi is 18.84. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Lucid Diagnostics Inc Daily Relative Strength Index (RSI) ChartLucid Diagnostics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lucid Diagnostics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lucid Diagnostics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Lucid Diagnostics Inc Daily Stochastic Oscillator ChartLucid Diagnostics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lucid Diagnostics Inc. The current cci is -162.48415848.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Lucid Diagnostics Inc Daily Commodity Channel Index (CCI) ChartLucid Diagnostics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lucid Diagnostics Inc. The current cmo is -73.34305643.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lucid Diagnostics Inc Daily Chande Momentum Oscillator (CMO) ChartLucid Diagnostics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lucid Diagnostics Inc. The current willr is -97.01926572.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Lucid Diagnostics Inc Daily Williams %R ChartLucid Diagnostics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lucid Diagnostics Inc.

Lucid Diagnostics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lucid Diagnostics Inc. The current atr is 0.06793634.

Lucid Diagnostics Inc Daily Average True Range (ATR) ChartLucid Diagnostics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lucid Diagnostics Inc. The current obv is -3,205,779.

Lucid Diagnostics Inc Daily On-Balance Volume (OBV) ChartLucid Diagnostics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lucid Diagnostics Inc. The current mfi is 2.42651117.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Lucid Diagnostics Inc Daily Money Flow Index (MFI) ChartLucid Diagnostics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lucid Diagnostics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Lucid Diagnostics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lucid Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5018.841
Ma 20Greater thanMa 500.848
Ma 50Greater thanMa 1001.068
Ma 100Greater thanMa 2001.238
OpenGreater thanClose0.730
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lucid Diagnostics Inc with someone you think should read this too:
  • Are you bullish or bearish on Lucid Diagnostics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lucid Diagnostics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lucid Diagnostics Inc

I send you an email if I find something interesting about Lucid Diagnostics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Lucid Diagnostics Inc.

Receive notifications about Lucid Diagnostics Inc in your mailbox!